Business Context and Reporting Period
Company: NeoGenomics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 18, 2025
Subject: Executive leadership changes, specifically the promotion of the Chief Commercial Officer to President & Chief Operating Officer and the elimination of the Chief Operations Officer role.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and organizational restructuring.
Material Changes
- Executive Promotion: Warren Stone, currently Chief Commercial Officer, is promoted to President & Chief Operating Officer, effective April 1, 2025.
- Role Elimination: The Chief Operations Officer position is being eliminated. Melody Harris will no longer hold this role or be a named executive officer effective April 1, 2025.
- Transition Plan: Ms. Harris is expected to remain with the company through May 2025 to facilitate the transition of responsibilities.
Management Commentary and Compensation Details
In connection with Mr. Stone's new role, the following compensation adjustments are effective April 1, 2025:
- Base Salary: Increased to $650,000 per year.
- Target Annual Incentive: Increased to 70% of annual base salary.
- Annual Equity Awards: Target grant date fair value increased to $3,000,000.
- Incremental Grant: An additional equity grant with an aggregate target grant date fair value of approximately $1,000,000 (comprised of premium-priced stock options and restricted stock units).
- Existing Awards: Vesting schedules for stock options and restricted stock units granted on February 21, 2025, have been adjusted.
Investor Verification Checklist
- Verify the effective date of the leadership transition (April 1, 2025) and the departure timeline for the former Chief Operations Officer (May 2025).
- Review the specific terms of the incremental $1,000,000 equity grant and the adjusted vesting schedules for existing awards.
- Confirm the impact of the organizational restructuring on the company's operational strategy as detailed in the attached press release (Exhibit 99.1).